CRBP trade ideas
$CRBP BIO STOCK >200 MA Break @ 7.08 > Median Analyst Target 26+$CRBP BIO STOCK >200 MA Break @ 7.08 > Median Analyst Target 26+
Chart is setting up with the 200 MA break for a early set up to the Golden Cross, as the 50 MA is edging up. The stock will Blue Sky with a 11 break. Most Analysts have a target over 26 +.
Fundamental Catalysts
With Data coming and potential approvals could be " the excuse" to what the chart is telling us. With a median target of 26+ puts tremendous upside with limited downside here.
I expect this to be rich with catalysts, data points, and potential approvals till years end.
The Phase 2 -3 studies
dermatomyositis and lupus
cystic fibrosis
systemic sclerosis
seekingalpha.com
CRBP closed right above treadlineWatching for either a bounce off past 10 day SMA or a breakdown to decide either short or long. RSI is about the same level as the previous bounce. Has bad news on its cystic fibrosis results and an investigation invloving possible fraud... looks more like a short, but could still go either way. Happy Trading!
NASDAQ:CRBP